Recombinant Human RCAS1 / EBAG9 protein (His tag)

Recombinant Human RCAS1 / EBAG9 protein (His tag)
Artikelnummer
ELSPDEH100304-100
Verpackungseinheit
100 µg
Hersteller
Elabscience Biotechnology

Verfügbarkeit: wird geladen...
Preis wird geladen...
Abbreviation: RCAS1;EBAG9

Target Synonym: Receptor-binding cancer antigen expressed on SiSo cells;EBAG9;RCAS1;Cancer-associated surface antigen RCAS1;Estrogen receptor-binding fragment-associated gene 9 protein

Target Species: Human

Expression Host: E.coli

Fusion Tag: N-His

UNIProt ID: O00559

Background: RCAS1, also known as EBAG9, is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. RCAS1 gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor which binds to the estrogen-responsive element (ERE) found in the 5'-flanking region of RCAS1 gene. Two transcript variants differing in the 5' UTR, but encoding the same protein, have been identified for RCAS1 gene. EBAG9 may participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases.

Sequence: Arg 28-Ser 213

Purity: > 95 % as determined by reducing SDS-PAGE.

Formulation: Lyophilized from sterile PBS, pH 7.4.
Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.

Endotoxin: Please contact us for more information.
Mehr Informationen
Artikelnummer ELSPDEH100304-100
Hersteller Elabscience Biotechnology
Hersteller Artikelnummer ELA-PDEH100304-100
Verpackungseinheit 100 µg
Mengeneinheit STK
Produktinformation (PDF) Download
MSDS (PDF) Download